Titlebook: Leukemia; Recent Developments Eckhard Thiel,Stephan Thierfelder Book 1984 Springer-Verlag Berlin Heidelberg 1984 Leuk?mie.bone marrow.chem

FLAGR

Defense

Cytogenetics in Leukemia: Implications for Pathogenesis and Prognosis,ool for both researchers and practicing physicians. It has revived the stem cell concept, contributed to our understanding of clonal evolution and progression, and climaxed recently in the localization of “cancer genes” on certain chromosome segments. For the physician, chromosome analysis of leukem

legacy

,“Atypical” Leukemias: Preleukemia, Smoldering Leukemia and Hypoplastic Leukemia, arisen from the use of different criteria for the definition of the various entities. The application of morphological criteria has led to the separation of conditions without recognizable leukemic blasts, e.g., refractory anemia [11] and refractory anemia with ring sideroblasts [11], from subentit

搖曳的微光

Biological and Clinical Significance of Immunological Cell Markers in Leukemia,nother case of leukocythemia as suppuration of the blood, Virchow suggested a disturbed regulation of maturation as the underlying pathophysiologic mechanism of the disease. After a century of increasing knowledge of morphologic criteria owing to the use of the microscope and of specialized staining

厭煩

CAPE

Epithelium

缺陷

Acute Myelogenous Leukemia: Current Status of Therapy in Adults, Infiltration of the bone marrow by these leukemia cells results in the impairment of normal hematopoiesis, with resultant anemia, granulocytopenia, and thrombocytopenia. If untreated the disease is rapidly fatal, with a median survival of less than 2 months. Death frequently results from infection,

該得

Management of CLL and Allied Disorders with Reference to Their Immunology and Proliferation Kinetic progress that has been achieved in recent years in the definition of phenotype and function of leukemic lymphocytes, a more clearcut distinction of the similar but separate entities of B-type chronic lymphocytic leukemia (B-CLL), prolymphocyte leukemia (PLL), immunocytoma (IC), and T-CLL has become

Spongy-Bone